Suchergebnisse - "Taub, Jeffrey W"

PubPharm (210)

31

When it comes to drug access, should children be considered small adults? Countering coverage denials of FLT3 inhibitors in children with FLT3‐ITD AML

enthalten in: Pediatric Blood & Cancer | 2021

von Knight, T. | Ge, Y. | Taub, J. | +2

32

Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation

enthalten in: Pediatric Blood & Cancer | 2021

von Persaud, Y. | Seddiq, M. | Wu, Y. | +6

33

Targeting mitochondrial respiration for the treatment of acute myeloid leukemia

enthalten in: Biochemical pharmacology | 2020

von Carter, J. | Hege, K. | Kalpage, H. | +4

34

Targeting multiple signaling pathways : the new approach to acute myeloid leukemia therapy

enthalten in: Signal transduction and targeted therapy | 2020

von Carter, J. | Hege, K. | Yang, J. | +6

35

Delayed Granulocyte Colony-Stimulating Factor (G-CSF) Administration after Chemotherapy Reduces Total G-CSF Doses without Affecting Neutrophil Recovery in a Randomized Clinical Study in Children with Solid Tumors

enthalten in: Pediatric hematology and oncology | 2020

von Yankelevich, M. | Hoogstra, D. | Abrams, J. | +3

36

Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia

enthalten in: Cancer | 2020

von Karol, S. | Cooper, T. | Mead, P. | +15

37

Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation

enthalten in: Cancers | 2020

von Liu, F. | Kalpage, H. | Wang, D. | +13

38

COVID-19 and childhood acute lymphoblastic leukemia

enthalten in: Pediatric blood & cancer | 2020

von Taub, J. | Ge, Y. | Xavier, A.

CommentIn: Pediatr Blood Cancer. 2020 Dec;67(12):e28481. - PMID 32860652

39

Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia : A Report From the Children's Oncology Group Protocol AAML0431

enthalten in: Archives of pathology & laboratory medicine | 2020

von Mast, K. | Taub, J. | Alonzo, T. | +12

40

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

enthalten in: Signal transduction and targeted therapy | 2020

von Luedtke, D. | Su, Y. | Ma, J. | +10